This page contains a Flash digital edition of a book.
best technologies. broadest expertise. faster development.


for glass-free injectables.


best technologies. broadest expertise. faster development.


best technologies. best technologies. broadest expertise.


best technologies. broadest expertise. faster development.


best technologies. broadest expertise. faster development.


best technologies. broadest expertise. faster development.


broadest expertise. faster development.


faster development.


Our next generation glass-free injectable solution utilizes advanced aseptic processing based on QbD principles to diminish risk for your sterile manufacturing challenges.


Catalent. More products. Better treatments. Reliably supplied.™


best technologies. broadest expertise. faster development.


OVER 95% REDUCTION IN PARTICULATES  STERILITY ASSURANCE THROUGH AUTOMATION  IMPROVED RELIABILITY OF SUPPLY


new sterile technologies sterile technologies Catalent


Acquires Micron Technologies


sterile technologies sterile technologies sterile technologies


sterile technologiessterile technologies reduce


the risk of injectable filling


the risk of injectable filling


the risk with injectable filling


the risk with injectable filling


the risk of injectable filling


the risk of injectable filling


reduce reduce reduce reduce


the risk of injectable filling


reduce reduce


leader in particle size engineering


rp scherer softgel technologies controlled release technologies optimelt™ osdrc®


hme technology optidose™


Our 18 R&D teams in 10 countries are now working on 500+ projects, applying multiple proven and innovative drug delivery technologies to help you deliver optimal release profi les, enhanced bioavailability and better dose forms—preferred by patients and payers.


technology zydis® fast-dissolve technologies


Our 1 18 R& tea foovenn i adv nasept™ technology: technology— optidose™


wookiking on 500 p ojects, a


TECHNOLOGY SELECTION & APPLICATION  FORMULATION & ANALYTICAL SERVICES  CLINICAL & COMMERCIAL SUPPLY  TAILORED OR END-TO-END SOLUTIONS orvevenn ad d in o tiased on QbD principles to diminish risk for your sterile manufacturi –ng challenges. Catalent. More products. Better treatments. s Reliably supp ied.™ Catalent. More products. Better treatments. Reliably supplied.™


ven and innovative drug de ivery technologies p proven and innovative drug delivery technologies to toe hlp you d l ver r oimal r lele e e pfi fi le enhanced oaoavlaibilbily and de bette dosose rmms—rerefer bred byatatnetnts ad da payers.


Our 18 R&D teams in 10 countries are now working on 500+ projects, applying multiple proven and innovative drug delivery technologies to help you deliver optimal release profi les, enhanced bioavaislabil 1ity and better dose ow forms—preferred by patients and payers.


Our 18 R&D teams in 10 countries are now working on 500+ projects, applying multiple proven and innovative drug delivery technologies to help you deliver optimal release profi les, enhanced bioavailability and better dose forms—preferred by patients and payers.


Our 18 R&D teams in 10 countries are now Our 18 R&D teamss in 10 countrieess are n now


enhanced bioavailability and better dose e enhanced bioavailability and better dose fo fors—p pferred by pn p QbDiei s an n p yers.


TECHNOLOGY SELECTION & APPLICATION  FORMULATION & ANALYTICAL SERVICES  CLINICAL & COMMERCIAL SUPPLY  TAILORED OR END-TO-END SOLUTIONS OVER 95% REDUCTION IN PARTICULATES  STERILITY ASSURANCE THROUGH AUTOMATION  IMPROVED RELIABILITY OF SUPPLY


TECHNOLOGY SELECTION & APPLICATION  FORMULATION & ANALYTICAL SERVICES  CLINICAL & COMMERCIAL SUPPLY  TAILORED OR END-TO-END SOLUTIONS Catalent. More products. Better treatments. Reliably supplcatalent.ied.™ us + 1 888 SOL 888 SOLUTION eu 00800 8855 6178 catalent.com/advasept


Our 18 R&D teams in 10 countries are now working on 500+ projects, applying multiple proven and innovative drug delivery technologies to help you deliver optimal release profi les, enhanced bioavailability and better dose forms—preferred by patients and payers.


orking on 500+ projects, applying multiple wrorking on 500+ projects, applying multiple


p wrorng on 500+ +r projects,p ap p ying mup p r p o n a


Our nnxt gtteion gltass--ffrreae i- jecttab e sa u ioo b ased b oas QbDn p QbD pres to emn sh r sk fo yo fo


Our next generation glas -free injectable solution utilizes advanced aseptic processing based on ed o prrin cipincipllein to l dis iin dimni for sk u s yo


to help you del biver optimal releas profi les,logies s to h help you deliver optimal release profi les,


forms—preferred by patients and payers. + 1 888 SOLUTION eu 00800 8855 6178 catalent.com/advasept forms—preferred by patients and payers.


Our next generation glass-free injectable solution utilizes advanced aseptic processing innonvavavte e u u d l very y ch


elp youe dielive optptimale reasas proro les,s, nhanced bi bi vai ala it ity an b tter r d e us


Our next gene a nera ss Our next geeerra ion glaion glee inr


advanced aseptic processing for glass-free injectables.


for glass-free injectables.


Our next generation glass-free injectable solution utilizes advanced aseptic processing based on QbD principles to diminish risk for your sterile manufacturing challenges. us + 1 888 SOLlent. More


ssnfjeece inle solution u ili


OVER 95% REDUCTION IN PARTICULATES  STERILITY ASSURANCE THROUGH AUTOMATION  IMPROVED RELIABILITY OF SUPPLY roducts. Better treatments. Reliably supplied.™


ased on QbD principles to diminish risk for your sterile manufacturing chal enges. Catalent. More products. Better treatments. Reliably supplied.™


technology spotlight


Catalent. More products. Better treatments. Reliably supplied.™ us + 1 888 SOLUTION eu 00800 8855 6178 solutions@catalent.com catalent.com


based on QbD principles to diminish risk for your sterile manufacturing challenges. technology


us + 1 888 SOLUTION eu 00800 8855 6178 solutions@catalent.com catalent.com abljectolblte sn l uttilize u dv s ced a taste-masking and higher dose options.


Catalent. More products. Better treatments. Reliably supplied.™ us + 1 888 SOLUTION eu 00800 8855 6178 catalent.com/advasept scip dim toiish riisksh rri yourrr ste ii e ma u ac ur ac uri


technology spotlight


spotlight


technology spotlight


ioznes ailizan adv asepdic e o e prng terrullre s maine ac ur ing chal lenge cgesl.enges.


technology spotlight


st adveancedansceepttic pro essng ternluff mattnuifngt chanllgenhals.


Catalent. More products. Better treatments. Reliably supplied.™ us + 1 888 SOLUTION eu 00800 8855 6178 solutions@catalent.com catalent.com


US + 1 888 SOLUTION (765 8846) EU 00800 8855 6178 solutions@catalent.com catalent.com


TECHNOLOGY SELECTION & APPLICATION  FORMULATION & ANALYTICAL SERVICES  CLINICAL & COMMERCIAL SUPPLY  TAILORED OR END-TO-END SOLUTIONS TECHNOLOGY SELECTION & APPLICATION  FORMULATION & ANALYTICAL SERVICES  CLINICAL & COMMERCIAL SUPPLY  TAILORED OR END-TO-END SOLUTIONS


TECHNOLOGY SELECTION & APPLICATION  FORMULATION & ANALYTICAL SERVICES  CLINICAL & COMMERCIAL SUPPLY  TAILORED OR END-TO-END SOLUTIONS


TECHNOLOGY SELECTION & APPLICATION  FORMULATION & ANALYTICAL SERVICES  CLINICAL & COMMERCIAL SUPPLY  TAILORED OR END-TO-END SOLUTIONS 274-CatalentAd2015-AdvaSept_R6D.indd 6


TECHNOLOGY SELECTION & APPLICATION  FORMULATION & ANALYTICAL SERVICES  CLINICAL & COMMERCIAL SUPPLY  TAILORED OR END-TO-END SOLUTIONS OVER 95% REDUCTION IN PARTICULATES  STERILITY ASSURANCE THROUGH AUTOMATION  IMPROVED RELIABILITY OF SUPPLY


274-CatalentAd2015-AdvaSept_R6D.indd 6 OVER 95% REDUCTION IN PARTICULATES  STERILITY ASSURANCE THROUGH AUTOMATION  IMPROVED RELIABILITY OF SUPPLY OVER 95% REDUCTION IN PARTICULATES  STERILITY ASSURANCE THROUGH AUTOMATION  IMPROVED RELIABILITY OF SUPPLY OVER 95% REDUCTION IN PARTICULATES  STERILITY ASSURANCE THROUGH AUTOMATION  IMPROVED RELIABILITY OF SUPPLY OVER 95% REDUCTION IN PARTICULATES  STERILITY ASSURANCE THROUGH AUTOMATION  IMPROVED RELIABILITY OF SUPPLY


Catalent. More products. Better treatments. Reliably supplied.™ us + 1 888 SOLUTION eu 00800 8855 6178 solutions@catalent.com catalent.com


Catalent. More products. Better treatments. Reliably supplied.™ us + 1 888 SOLUTION eu 00800 8855 6178 solutions@catalent.com catalent.com


CataUTION eu p 00800 8855 6178 solutions@ US + 1UTION eu 00800 8855 6178 solutionsom catalent. om/advasept us + 1 888 SOLUTION (765 8846) EU solutions@catalent.c@catalent.com catalent.com


Catalent. More products. Better treatments. Reliably supplied.™ us + 1 888 SOLUTION eu 00800 8855 6178 catalent.com/advasept


Catalent. More products. Better treatments. Reliably su plied.™ Catalent. More products. Better treatments. Reliably supplied.™


Catalent. More products. Better treatments. Reliably supplied.™ us + 1 888 SOLUTION eu 00800 8855 6178 catalent.com/advasept


10/1/14 4:36 PM 10/1/14 4:36 PM


com catalent.com


World’s best orally dissolvable tablet – about 3 seconds. Uniquely delivers small or large molecules. 20 Rx and OTC products in 50 markets. NEW taste-masking and higher dose options.


– bout 3 seconds. Uniquely delivers World’s best orally dissolvable tablet


World’s best orally dissolvable tablet small or large molecules. 20 Rx and


– about 3 seconds. Uniquely delivers small or large molecules. 20 Rx and OTC products in 50 markets. NEW


as prptcicssiiocessing


about 3 seconds. Uniquely delivers OTC products in 50 markets. NEW


World’s best orally dissolvable tablet – about 3 seconds. Uniquely delivers small or large molecules. 20 Rx and OTC products in 50 markets. NEW taste-masking and higher dose options.


mall or large molecules. 20 Rx and taste-masking and higher dose options.


OTC products in 50 markets. NEW taste-masking and higher dose options.


Our next generation glass-free injectable solution utilizes advanced aseptic processing iv dr drg ge dieliver te tecnhon logie


advanced aseptic processing for glass-free injectables.


technology spotlight


technology spotlight


wOur8 R&DD temm in in0 10 u glass- afree injectables. ™


proven advasept™


prrproven advasept™™ echnology— n advanced aseptic processing


proven advasept™ technology: advanced aseptic processing co conutritrse arereow


technology spotlight


™


Catalent. More products. Better treatments. Reliably supplied.™ us + 1 888 SOLUTION eu 00800 8855 6178 solutions@catalent.com catalent.com plyilng multiltliele


technology:


osdrc®osdrc® optidose™ technology osdrc®


optimelt™ optimelt™ optimelt™


osdrc® optidose™ technology osdrc® optidose™ hme technology


zydis® fast-dissolve technologies fast-dissolve technologies


zydis® fast-dissolve technologies zydis® fast-dissolve technologies


optidose™


technology technology


zydis® fast-dissolve technologies zydis®World’s best orally dissolvable tablet


World’s best orally dissolvable tablet – about 3 seconds. Uniquely delivers small or large molecules. 20 Rx and OTC products in 50 markets. NEW taste-masking and higher dose options.


controlled release technologies rp scherer softgel technologies


rp scherer softgel technologies controlled release technologies optimelt™


rp scherer softgel technologies osdrc®


World’s best orally dissolvable tablet – about 3 seconds. Uniquely delivers small or large molecules. 20 Rx and OTC products in 50 markets. NEW taste-masking and higher dose options.


rp scherer softgel technologies controlled release technologies


controlled release technologies hme technology


zydis® fast-dissolve te hme technology zydis® fast-dissolve te hme technology


World’s best orally dissolvable tablet – about 3 seconds. Uniquely delivers small or large molecules. 20 Rx and OTC products in 50 markets. NEW taste-masking and higher dose options.


hme technology technology


rp scherer softgel technologies controlled release technologies optimelt™


optidose™ optidose™


technology technology


hme technology hme technology


rp scherer softgel technologies controlled release technologies optimelt™ osdrc®


rp scherer softgel technologies controlled release technologies optimelt™


274-CatalentAd2015-AdvaSept_R6D.indd 6274-CatalentAd2015-AdvaSept_R6D.indd 6


274-CatalentAd2015-AdvaSept_R6D.indd 6


10/1/14 4:36 PM10/1/14 4:36 PM


10/1/14 4:36 P


˝ 2014 Catalent Pharma Solutions. All rights reserved. OSDrC is a registered trademark of Sanwa Kagaku Kenkyusho Co.


˝ 2014 Catalent Pharma Solutions. All rights reserved. OSDrC is a registered trademark of Sanwa Kagaku Kenkyusho Co.


˝ 2014 Catalent Pharma Solutions. All rights reserved. OSDrC is a registered trademark of Sanwa Kagaku Kenkyusho Co.


2014 Catalent Pharma Solutions. All rights reserved. OSDrC is a registered tr


˝ 2014 Catalent Pharma Solutions. All rights r


˝ 2014 Catalent Pharma Solutions. All rights reserved. OSDrC is a registered trademark of Sanwa Kagaku Kenkyusho Co.


˝ 2014 Catalent Pharma Solutions. All rights reserved. OSDrC is a registered trademark of Sanwa Kagaku Kenkyusho Co.


˝ 2014 Catalent Pharma Solutions. All rights reserved. OSDrC is a registered trademark of Sanwa Kagaku Kenkyusho Co.


ed trademark of Sanwa Kagaku Kenkyusho Co.


˝ 2014 Catalent Pharma Solutions. All rights reserved. OSDrC is a registered trademark of Sanwa Kagaku Kenkyusho Co.


˝ 2014 Catalent Pharma Solutions. All rights reserved. ˝ 2014 Catalent Pharma Solutions. All rights reserved.


˝ 2014 Catalent Pharma Solutions. All rights reserved. ˝ 2014 Catalent Pharma Solutions. All rights reserved.


˝ 2014 Catalent Pharma Solutions. All rights reserved.


˝ 2014 Catalent Pharma Solutions. All rights reserved.


˝ 2014 Catalent Pharma Solutions. All ri


˝ 2014 Catalent Pharma Solutions. All rights reserved.

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76